We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

193 hedge funds and large institutions have $1.23B invested in Ariad Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 59 increasing their positions, 62 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 24

38% more capital invested

Capital invested by funds: $888M → $1.23B (+$341M)

8% more funds holding

Funds holding: 179 → 193 (+14)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

5% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 62

31% less call options, than puts

Call options by funds: $19M | Put options by funds: $27.6M

Holders
193
Holders Change
+14
Holders Change %
+7.82%
% of All Funds
5.14%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
39
Increased
59
Reduced
62
Closed
24
Calls
$19M
Puts
$27.6M
Net Calls
-$8.59M
Net Calls Change
-$5.84M

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$53.8M
2
DCM
Discovery Capital Management
Connecticut
+$43.2M
3
Renaissance Technologies
Renaissance Technologies
New York
+$17.7M
4
Invesco
Invesco
Georgia
+$15.3M
5
Millennium Management
Millennium Management
New York
+$11.1M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9.13M
2
CCI
Columbus Circle Investors
-$6.91M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.88M
4
PC
PointState Capital
New York
-$6.65M
5
Ameriprise
Ameriprise
Minnesota
-$4.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$106M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$92.1M +$3.24M +437,583 +4%
PI
3
Putnam Investments
Massachusetts
$87M +$53.8M +7,275,773 +222%
Westfield Capital Management
4
Westfield Capital Management
Massachusetts
$76.7M +$7.39M +999,815 +12%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$75.7M -$227K -30,700 -0.3%
BFA
6
BlackRock Fund Advisors
California
$68.9M +$3.08M +417,084 +5%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$61M -$6.88M -931,000 -11%
CCM
8
Camber Capital Management
Massachusetts
$57.7M -$3.7M -500,000 -7%
DCM
9
Discovery Capital Management
Connecticut
$48.1M +$43.2M +5,842,050 New
State Street
10
State Street
Massachusetts
$47.1M -$568K -76,889 -1%
BIT
11
BlackRock Institutional Trust
California
$40.4M -$27.5K -3,714 -0.1%
PC
12
PointState Capital
New York
$37.1M -$6.65M -900,000 -17%
Invesco
13
Invesco
Georgia
$23.3M +$15.3M +2,064,874 +271%
Renaissance Technologies
14
Renaissance Technologies
New York
$22M +$17.7M +2,394,100 +851%
PAI
15
Palo Alto Investors
California
$18.4M – – –
Northern Trust
16
Northern Trust
Illinois
$16.8M +$224K +30,322 +2%
BNP Paribas Asset Management
17
BNP Paribas Asset Management
France
$16M +$1.13M +153,516 +9%
O
18
OppenheimerFunds
New York
$15.3M +$1.72M +232,360 +14%
Millennium Management
19
Millennium Management
New York
$13.6M +$11.1M +1,502,359 +1,054%
OM
20
Opaleye Management
Massachusetts
$12.4M -$185K -25,000 -2%
AIMCA
21
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$11.8M +$381K +51,470 +4%
Norges Bank
22
Norges Bank
Norway
$10.7M -$1.48M -200,632 -13%
GAI
23
General American Investors
New York
$9.89M – – –
HS
24
HighVista Strategies
Massachusetts
$9.89M – – –
Deutsche Bank
25
Deutsche Bank
Germany
$9.46M +$7.38M +997,802 +661%
1
2 3 4 5

ARIA Hedge Fund Activity: Q1 2015 in Review

193 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2015, worth a combined $1.23B — up 38% from $888M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ARIA positions and 24 closed out — a net gain of 15 holders — while 59 added to existing stakes and 62 trimmed.

The largest buyer was Putnam Investments, adding an estimated $53.8M. The largest seller was Susquehanna International Group, cutting an estimated $9.13M.

  • 193 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2015, up from 179 in Q4 2014.
  • Funds reported $1.23B of Ariad Pharmaceuticals Inc stock for Q1 2015, up 38% quarter-over-quarter.
  • 39 funds opened new Ariad Pharmaceuticals Inc positions in Q1 2015 and 24 closed out, a net change of +15 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2015 was Putnam Investments, an estimated $53.8M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2015 was Susquehanna International Group, an estimated $9.13M sold.

Based on aggregated 13F filings for Q1 2015.